Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jaffe ES (2013) Follicular lymphomas: a tapestry of common and contrasting threads. Haematologica 98(8):1163–1165

Article  PubMed  PubMed Central  Google Scholar 

Katzenberger T, Kalla J, Leich E, Stöcklein H, Hartmann E, Barnickel S et al (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113(5):1053–1061

Article  PubMed  CAS  Google Scholar 

Thorns C, Kalies K, Fischer U, Höfig K, Krokowski M, Feller AC et al (2007) Significant high expression of CD23 in follicular lymphoma of the inguinal region. Histopathology 50(6):716–719

Article  PubMed  CAS  Google Scholar 

Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH (2011) CD23 expression in follicular lymphoma: clinicopathologic correlations. Am J Clin Pathol 135(1):46–53

Article  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Araujo IB O, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–48.

Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229–1253

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xian RR, Xie Y, Haley LM, Yonescu R, Pallavajjala A, Pittaluga S et al (2020) CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. Blood Cancer J 10(6):69

Article  PubMed  PubMed Central  Google Scholar 

Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298–303

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bödör C, Grossmann V, Popov N, Okosun J, O’Riain C, Tan K et al (2013) EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122(18):3165–3168

Article  PubMed  PubMed Central  Google Scholar 

Correia C, Schneider PA, Dai H, Dogan A, Maurer MJ, Church AK et al (2015) BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 125(4):658–667

Article  PubMed  CAS  Google Scholar 

Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB et al (2014) Genetics of follicular lymphoma transformation. Cell Rep 6(1):130–140

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li H, Kaminski MS, Li Y, Yildiz M, Ouillette P, Jones S et al (2014) Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. Blood 123(10):1487–1498

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burack WR, Li H, Adlowitz D, Spence JM, Rimsza LM, Shadman M et al (2023) Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma. Blood Adv 7(17):5082–5090

Article  PubMed  PubMed Central  CAS  Google Scholar 

O’Shea D, O’Riain C, Taylor C, Waters R, Carlotti E, MacDougall F et al (2008) The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood 112(8):3126–3129

Article  PubMed  PubMed Central  Google Scholar 

Siddiqi IN, Friedman J, Barry-Holson KQ, Ma C, Thodima V, Kang I et al (2016) Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol 29(6):570–581

Article  PubMed  CAS  Google Scholar 

Nann D, Ramis-Zaldivar JE, Müller I, Gonzalez-Farre B, Schmidt J, Egan C et al (2020) Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. Blood Adv 4(22):5652–5665

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kastenhuber ER, Lowe SW (2017) Putting p53 in Context. Cell 170(6):1062–1078

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES et al (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82(7):1994–2004

Article  PubMed  CAS  Google Scholar 

Khanlari M, Wang SA, Fowler NH, Tang G, Saluja K, Muzzafar T et al (2021) Concurrent TP53 mutation and deletion in refractory low-grade follicular lymphoma. Clin Lymphoma Myeloma Leuk 21(7):e626–e629